Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

The Index › Metabolic medicine › Whose sales may the drugs shrink?

Mondelez

MDLZ

Mondelez sells snacks such as biscuits, chocolate and gum. We follow it because its sales depend on eating habits that weight-loss drugs and health trends may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
MDLZ
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$66.44
close of 9 Nov 2026 · Massive and Yahoo agree
The day's range$65.34 – $66.62
9 Nov 2026 · both providers agree
52-week range$51.20 – $68.75
intraday low 8 Jan 2026 · intraday high 5 Nov 2026 · 251 sessions to 9 Nov 2026 · both providers agree
Market value$84.1 billion
the 9 Nov 2026 close × 1,265,838,379 shares outstanding on the 10-Q cover, as of 26 Oct 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

29 Oct 202610-Q · period ending 30 Sep 2026
29 Oct 20268-K · period ending 29 Oct 2026
28 Jul 202610-Q · period ending 30 Jun 2026
28 Jul 20268-K · period ending 28 Jul 2026
18 Jun 20268-K · period ending 15 Jun 2026
26 May 20268-K · period ending 20 May 2026
28 Apr 202610-Q · period ending 31 Mar 2026
28 Apr 20268-K · period ending 28 Apr 2026
18 Feb 20268-K · period ending 18 Feb 2026
4 Feb 202610-K · period ending 31 Dec 2025
3 Feb 20268-K · period ending 3 Feb 2026
30 Jan 20268-K · period ending 27 Jan 2026
28 Oct 202510-Q · period ending 30 Sep 2025
28 Oct 20258-K · period ending 28 Oct 2025
29 Jul 202510-Q · period ending 30 Jun 2025
29 Jul 20258-K · period ending 29 Jul 2025
27 May 20258-K · period ending 20 May 2025
6 May 20258-K · period ending 1 May 2025
29 Apr 202510-Q · period ending 31 Mar 2025
29 Apr 20258-K · period ending 29 Apr 2025
20 Feb 20258-K · period ending 19 Feb 2025
18 Feb 20258-K · period ending 18 Feb 2025
5 Feb 202510-K · period ending 31 Dec 2024
4 Feb 20258-K · period ending 4 Feb 2025
27 Jan 20258-K · period ending 24 Jan 2025
15 Jan 20258-K · period ending 15 Jan 2025
3 Dec 20248-K · period ending 29 Nov 2024

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-07-28 · period ending 2026-06-30

Read the filing

Machine-readable

/index/MDLZ.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Whose sales may the drugs shrink?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-07-28 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Mondelez. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-07-28
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)